u/osman_brandt

Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.

write the reconstitution date on the vial

A stability statement is only meaningful with its conditions attached: temperature, duration, light exposure, and whether it covers powder or solution. Ask which.

That is a report count, not a test count, and it changes how thin the evidence base actually is.

Cosigning the regional stock point. Ordering from a warehouse in the UK took the whole question off my table.

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them.

Research-use-only material is not approved for human use. In this board that is not a formality — it is the reason the clinical evidence base is as thin as it is.

the EMA authorises, member states decide who pays

fridge, not freezer, once it is in solution

Wrote the reconstitution date on the vial for the first time last year. Have never once since wondered how old a solution is.

a summer lane and a winter lane are different lanes

Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.

Same. A batch-specific document requested before payment costs nothing and filters an enormous amount.

I would separate the two claims. The site being newly registered is checkable. The motive you are inferring is not.

Do you have the mass spectrum?

Wrote the reconstitution date on the vial for the first time last year. Have never once since wondered how old a solution is.

Push back: you cannot infer degradation from a temperature excursion alone. That is what testing is for.

report it here with dates, not adjectives

It is a fifteen-residue peptide with a published sequence, which makes synthesis straightforward and makes identity verification the meaningful test rather than an optional extra.

Yes — keep both the prescription and the receipt. Claims processes ask for both and never at a convenient moment.

report it here with dates, not adjectives

light matters more than people think for some of these

Cosigning the regional stock point. Ordering from a warehouse in Canada took the whole question off my table.

Ask for the batch-specific certificate before payment. Any operation with a quality system behind it can produce one; the request costs you nothing and it filters hard.

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

Not convinced. A high purity figure with no identity confirmation tells you the sample is homogeneous, not that it is what you ordered.

The evidence base, described honestly, which almost no summary of it does.

Disagreeing with this line: that paper is in a rodent model and it is being quoted as a human result.

Not convinced. A warm pack on day six is expected behaviour from a pack designed for four.

Every claim I could trace in this board went back to about four papers. That was a sobering afternoon.

Small fix — fifteen residues, not seventeen. The sequence is public and easy to check.

a shop that will only talk off-platform has told you something

Not convinced.

This is the point that should be at the top of every thread here. Identity first.

Cosigning the regional stock point.

osman_eriksen is right that the pack failing is not the material failing. Two separate claims.

How many days in transit, and which month?

Gel packs are designed for a duty cycle. A liquid pack at the end of a longer-than-expected transit is a pack behaving as specified, not evidence of an excursion in the vial.

Reported something here with dates and screenshots and was asked for the document trail. Fair challenge, and it made the report worth reading.